WUHAN KEQIAN BIOLOGY CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.39 CNY | -1.31% |
|
+4.32% | -14.67% |
ETFs positioned on Wuhan Keqian Biology Co.,Ltd
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.14% | - |
Wuhan Keqian Biology Co Ltd is a China-based company mainly engaged in the research and development, production, sales of veterinary biological products and the provision of animal epidemic prevention technical services. The Company's main products are vaccines for swine and poultry. The Company mainly conducts its businesses within the China market.
Sector
Pharmaceuticals
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
17.39
CNY
Average target price
24.75
CNY
Spread / Average Target
+42.32%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -14.67% | 1.12B | |
| -19.73% | 72.39B | |
| -11.01% | 6.54B | |
| +15.88% | 3.43B | |
| -2.92% | 3.12B | |
| -0.68% | 1.4B | |
| -17.27% | 1.34B | |
| -2.73% | 1.26B | |
| -5.37% | 990M | |
| -24.06% | 805M |
- Stock Market
- Equities
- 688526 Stock
- Funds and ETFs Wuhan Keqian Biology Co.,Ltd
